Radiation oncologist Dr. Charles Kunos recently joined Markey to serve as medical director of Markey’s Clinical Research Office (CRO).
LEXINGTON, Ky. (May 25, 2021) – The University of Kentucky Markey Cancer Center announces that radiation oncologist Dr. Charles Kunos will join the center and serve as medical director of Markey’s Clinical Research Office (CRO).
In this role, Kunos will work to improve accrual to cancer clinical trials, maintain quality oversight of CRO processes and activity, and lead MCC’s efforts to decrease time-to-activation across all types of trials, in preparation for renewal of NCI designation in September 2022. Kunos will work closely with MCC senior leadership to ensure adequate resources and financial oversight of the CRO.
LEXINGTON,
Ky. (April 27, 2021) – A recent study by University of Kentucky Markey Cancer Center researchers looked into the association of financial burden with health insurance literacy in colorectal cancer patients.
Recently published in Supportive Care in Cancer, the team utilized the Kentucky Cancer Registry data to collect surveys from colorectal cancer survivors in Kentucky to identify if there was a correlation between individuals suffering from financial toxicity and comprehension of health insurance.
Financial toxicity is the accumulation of the financial costs and financial distress or hardship that can affect the health and wellbeing of cancer survivors. Studies cited in the article highlight how survivors suffering from financial toxicity had a poorer quality of life, decreased survival, increased symptom burden, and a decrease in treatment compliance.
Nathan Vanderford, director of the SHE in Oncology program, also oversees ACTION, Markey s other successful cancer program aimed at high school and college students.
LEXINGTON, Ky. (April 19, 2021) – This summer, the University of Kentucky Markey Cancer Center is launching the Summer HealthCare Experience (SHE) in Oncology program, aimed at empowering high school girls throughout Kentucky to learn more about the field of cancer medicine and research. The inaugural SHE in Oncology program will be held July 12-23 and will be virtual this year due to the ongoing pandemic.
Funded by the American Cancer Society, SHE in Oncology will offer experiences, activities and discussions to help introduce teen girls to the wide range of career and leadership opportunities in oncology. Benefits of the program include:
of
LEXINGTON, Ky. (April 12, 2021) With COVID-19 vaccinations continuing to roll out across the country, the University of Kentucky Markey Cancer Center strongly encourages both cancer survivors, caregivers and patients in active cancer treatment to receive one of the available vaccines. This is in line with recommendations from both the Centers for Disease Control and Prevention (CDC) and the American Cancer Society.
As of Monday, April 5, any Kentuckian age 16 and up is eligible to get the Pfizer vaccine. The Moderna and Johnson & Johnson vaccines are available to anyone age 18 and older. Given the higher rates of severe COVID-19 infection in cancer patients, the American Society of Clinical Oncology and the CDC recommend that cancer patients strongly consider vaccination against COVID-19, said Dr. Frederick R. Ueland, gynecologic oncologist and director of oncology clinical operations at the UK Markey Cancer Center. This includes cancer survivors, most patients undergo